W. H. Organisation, In: 2nd edition: World Health Organisation, 2010.

N. J. White, Qinghaosu (artemisinin): the price of success, Science, vol.320, issue.5874, pp.330-334, 2008.

A. P. Phyo and L. Von-seidlein, Challenges to replace ACT as first-line drug, Malar J, vol.16, issue.1, p.296, 2017.

A. M. Dondorp, S. Yeung, L. White, C. Nguon, N. P. Day et al., Artemisinin resistance: current status and scenarios for containment, Nat Rev Microbiol, vol.8, issue.4, pp.272-80, 2010.

A. P. Phyo, S. Nkhoma, K. Stepniewska, E. A. Ashley, S. Nair et al., Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study, vol.379, pp.1960-1966, 2012.

A. M. Dondorp, F. Nosten, P. Yi, D. Das, A. P. Phyo et al., Artemisinin resistance in Plasmodium falciparum malaria, N Engl J Med, vol.361, issue.5, pp.455-67, 2009.

H. Noedl, Y. Se, K. Schaecher, B. L. Smith, D. Socheat et al., Evidence of artemisinin-resistant malaria in western Cambodia, N Engl J Med, vol.359, issue.24, pp.2619-2639, 2008.

T. T. Hien, N. T. Thuy-nhien, N. H. Phu, M. F. Boni, N. V. Thanh et al., In vivo susceptibility of Plasmodium falciparum to artesunate in, vol.11, p.355, 2012.

M. P. Kyaw, M. H. Nyunt, K. Chit, M. M. Aye, K. H. Aye et al., Reduced susceptibility of Plasmodium falciparum to artesunate in southern Myanmar, PLoS One, vol.8, issue.3, p.57689, 2013.

E. A. Ashley, M. Dhorda, R. M. Fairhurst, C. Amaratunga, P. Lim et al., Spread of artemisinin resistance in Plasmodium falciparum malaria, N Engl J Med, vol.371, issue.5, pp.411-434, 2014.

D. Menard, N. Khim, J. Beghain, A. A. Adegnika, M. Shafiul-alam et al., A Worldwide Map of Plasmodium falciparum K13-Propeller Polymorphisms, N Engl J Med, vol.374, issue.25, pp.2453-64, 2016.
URL : https://hal.archives-ouvertes.fr/pasteur-01336483

M. Hawkes, A. L. Conroy, and K. C. Kain, Spread of artemisinin resistance in malaria, N Engl J Med, vol.371, issue.20, pp.1944-1949, 2014.

K. B. Beshir, C. J. Sutherland, P. Sawa, C. J. Drakeley, L. Okell et al., Residual Plasmodium falciparum parasitemia in Kenyan children after artemisinin-combination therapy is associated with increased transmission to mosquitoes and parasite recurrence, J Infect Dis, vol.208, issue.12, pp.2017-2041, 2013.

A. M. Dondorp, R. M. Fairhurst, L. Slutsker, J. R. Macarthur, J. G. Breman et al., The threat of artemisininresistant malaria, N Engl J Med, vol.365, issue.12, pp.1073-1078, 2011.

R. Dell'acqua, C. Fabrizio, D. Gennaro, F. , L. Caputo et al., An intricate case of multidrug resistant Plasmodium falciparum isolate imported from Cambodia, Malar J, vol.16, issue.1, p.149, 2017.

M. Imwong, T. T. Hien, N. T. Thuy-nhien, A. M. Dondorp, and N. J. White, Spread of a single multidrug resistant malaria parasite lineage (PfPailin) to Vietnam, Lancet Infect Dis, vol.17, issue.10, pp.1022-1025, 2017.

B. Kwansa-bentum, I. Ayi, T. Suzuki, J. Otchere, T. Kumagai et al., Plasmodium falciparum isolates from southern Ghana exhibit polymorphisms in the SERCA-type PfATPase6 though sensitive to artesunate in vitro, Malar J, vol.10, p.187, 2011.

P. Phompradit, R. Wisedpanichkij, P. Muhamad, W. Chaijaroenkul, and K. Nabangchang, Molecular analysis of pfatp6 and pfmdr1 polymorphisms and their association with in vitro sensitivity in Plasmodium falciparum isolates from the Thai-Myanmar border, Acta Trop, vol.120, issue.1-2, pp.130-135, 2011.

D. R. Pillai, R. Lau, K. Khairnar, R. Lepore, A. Via et al., Artemether resistance in vitro is linked to mutations in PfATP6 that also interact with mutations in PfMDR1 in travellers returning with Plasmodium falciparum infections, Malar J, vol.11, p.131, 2012.

R. Jambou, E. Legrand, M. Niang, N. Khim, P. Lim et al., Resistance of Plasmodium falciparum field isolates to in-vitro artemether and point mutations of the SERCA-type PfATPase6, Lancet, vol.366, issue.9501, pp.1960-1963, 2005.
URL : https://hal.archives-ouvertes.fr/pasteur-00590989

A. Afonso, P. Hunt, S. Cheesman, A. C. Alves, C. V. Cunha et al., Malaria parasites can develop stable resistance to artemisinin but lack mutations in candidate genes atp6 (encoding the sarcoplasmic and endoplasmic reticulum Ca2+ ATPase), tctp, mdr1, and cg10, Antimicrob Agents Chemother, vol.50, issue.2, pp.480-489, 2006.

S. K. Puri and R. Chandra, Plasmodium vinckei: selection of a strain exhibiting stable resistance to arteether, Exp Parasitol, vol.114, issue.2, pp.129-161, 2006.

B. Witkowski, J. Lelievre, M. J. Barragan, V. Laurent, X. Z. Su et al., Increased tolerance to artemisinin in Plasmodium falciparum is mediated by a quiescence mechanism, Antimicrob Agents Chemother, vol.54, issue.5, pp.1872-1879, 2010.

Z. Wang, M. Cabrera, J. Yang, L. Yuan, B. Gupta et al., Genome-wide association analysis identifies genetic loci associated with resistance to multiple antimalarials in Plasmodium falciparum from China-Myanmar border, Sci Rep, vol.6, p.33891, 2016.

S. Mok, E. A. Ashley, P. E. Ferreira, L. Zhu, Z. Lin et al., Population transcriptomics of human malaria parasites reveals the mechanism of artemisinin resistance, Science, vol.47, issue.6220, pp.431-436, 2014.

I. H. Cheeseman, B. A. Miller, S. Nair, S. Nkhoma, A. Tan et al., A major genome region underlying artemisinin resistance in malaria, Science, vol.336, issue.6077, pp.79-82, 2012.

J. Wang, C. J. Zhang, W. N. Chia, C. C. Loh, Z. Li et al., Haem-activated promiscuous targeting of artemisinin in Plasmodium falciparum, Nat Commun, vol.6, p.10111, 2015.

G. Siddiqui, A. Srivastava, A. S. Russell, and D. J. Creek, Multi-omics Based Identification of Specific Biochemical Changes Associated With PfKelch13Mutant Artemisinin-Resistant Plasmodium falciparum, J Infect Dis, vol.215, issue.9, pp.1435-1479, 2017.

B. Witkowski, C. Amaratunga, N. Khim, S. Sreng, P. Chim et al., Novel phenotypic assays for the detection of artemisinin-resistant Plasmodium falciparum malaria in Cambodia: in-vitro and ex-vivo drug-response studies, Lancet Infect Dis, vol.13, issue.12, pp.1043-1052, 2013.
URL : https://hal.archives-ouvertes.fr/pasteur-00863935

K. Chotivanich, R. Tripura, D. Das, P. Yi, N. P. Day et al., Laboratory detection of artemisininresistant Plasmodium falciparum, Antimicrob Agents Chemother, vol.58, issue.6, pp.3157-61, 2014.

L. Arnold, R. K. Tyagi, P. Meija, C. Swetman, J. Gleeson et al., Further improvements of the P. falciparum humanized mouse model, PLoS One, vol.6, issue.3, p.18045, 2011.

E. Badell, C. Oeuvray, A. Moreno, S. Soe, N. Van-rooijen et al., Human malaria in immunocompromised mice: an in vivo model to study defense mechanisms against Plasmodium falciparum, J Exp Med, vol.192, issue.11, pp.1653-60, 2000.

T. Fandeur, S. Bonnefoy, and O. Mercereau-puijalon, In vivo and in vitro derived Palo Alto lines of Plasmodium falciparum are genetically unrelated, Mol Biochem Parasitol, vol.47, issue.2, pp.167-78, 1991.

W. A. Siddiqui, J. V. Schnell, and Q. M. Geiman, A model in vitro system to test the susceptibility of human malarial parasites to antimalarial drugs. The American journal of tropical medicine and hygiene, vol.21, pp.393-402, 1972.

S. De-lucia, I. Tsamesidis, M. C. Pau, K. R. Kesely, A. Pantaleo et al., Induction of high tolerance to artemisinin by sub-lethal administration: A new in vitro model of P. falciparum, PloS One, vol.13, issue.1, p.191084, 2018.

A. W. Rowe, E. Eyster, and A. Kellner, Liquid nitrogen preservation of red blood cells for transfusion; a low glycerol-rapid freeze procedure, Cryobiology, vol.5, issue.2, pp.119-147, 1968.

C. Lambros and J. P. Vanderberg, Synchronization of Plasmodium falciparum erythrocytic stages in culture, J Parasitol, vol.65, issue.3, pp.418-438, 1979.

R. T. Reese, S. G. Langreth, and W. Trager, Isolation of stages of the human parasite Plasmodium falciparum from culture and from animal blood, Bull World Health Organ, vol.57, issue.1, pp.53-61, 1979.

P. Druilhe, A. Moreno, C. Blanc, P. H. Brasseur, and P. Jacquier, A colorimetric in vitro drug sensitivity assay for Plasmodium falciparum based on a highly sensitive double-site lactate dehydrogenase antigen-capture enzyme-linked immunosorbent assay. The American journal of tropical medicine and hygiene, vol.64, pp.233-274, 2001.

R. E. Desjardins, C. J. Canfield, J. D. Haynes, and J. D. Chulay, Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique, Antimicrob Agents Chemother, vol.16, issue.6, pp.710-718, 1979.

A. Moreno, E. Badell, N. Van-rooijen, and P. Druilhe, Human malaria in immunocompromised mice: new in vivo model for chemotherapy studies, Antimicrob Agents Chemother, vol.45, issue.6, pp.1847-53, 2001.

E. M. Hodel, B. Zanolari, T. Mercier, J. Biollaz, J. Keiser et al., A single LC-tandem mass spectrometry method for the simultaneous determination of 14 antimalarial drugs and their metabolites in human plasma, J Chromatogr B Anal Technol Biomed Life Sci, vol.877, issue.10, pp.867-86, 2009.

P. Hunt, A. Afonso, A. Creasey, R. Culleton, A. B. Sidhu et al., Gene encoding a deubiquitinating enzyme is mutated in artesunate-and chloroquine-resistant rodent malaria parasites, Mol Microbiol, vol.65, issue.1, pp.27-40, 2007.

S. Takala-harrison, T. G. Clark, C. G. Jacob, M. P. Cummings, O. Miotto et al., Genetic loci associated with delayed clearance of Plasmodium falciparum following artemisinin treatment in Southeast Asia, Proc Natl Acad Sci, vol.110, issue.1, pp.240-245, 2013.

F. Ariey, B. Witkowski, C. Amaratunga, J. Beghain, A. C. Langlois et al., A molecular marker of artemisinin-resistant Plasmodium falciparum malaria, Nature, vol.505, issue.7481, pp.50-55, 2014.
URL : https://hal.archives-ouvertes.fr/pasteur-00921203

S. Takala-harrison, C. G. Jacob, C. Arze, M. P. Cummings, J. C. Silva et al., Independent emergence of artemisinin resistance mutations among Plasmodium falciparum in Southeast Asia, J Infect Dis, vol.211, issue.5, pp.670-679, 2015.

L. K. Basco and P. Ringwald, Molecular epidemiology of malaria in Yaounde, Cameroon. III. Analysis of chloroquine resistance and point mutations in the multidrug resistance 1 (pfmdr 1) gene of Plasmodium falciparum. The American journal of tropical medicine and hygiene, vol.59, pp.577-81, 1998.

R. N. Price, A. C. Uhlemann, A. Brockman, R. Mcgready, A. E. Phaipun et al., Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number, Lancet, vol.364, issue.9432, pp.438-485, 2004.

A. Nontprasert, S. Pukrittayakamee, M. Nosten-bertrand, S. Vanijanonta, and N. J. White, Studies of the neurotoxicity of oral artemisinin derivatives in mice. The American journal of tropical medicine and hygiene, vol.62, pp.409-421, 2000.

H. S. Nagesha, G. J. Casey, K. H. Rieckmann, D. J. Fryauff, B. S. Laksana et al., New haplotypes of the Plasmodium falciparum chloroquine resistance transporter (pfcrt) gene among chloroquine-resistant parasite isolates. The American journal of tropical medicine and hygiene, vol.68, pp.398-402, 2003.

D. Menard, V. Andriantsoanirina, N. Khim, A. Ratsimbasoa, B. Witkowski et al., Global analysis of Plasmodium falciparum Na(+)/H(+) exchanger (pfnhe-1) allele polymorphism and its usefulness as a marker of in vitro resistance to quinine, Int J Parasitol Drugs Drug Resist, vol.3, pp.8-19, 2013.

N. J. White, W. Pongtavornpinyo, R. J. Maude, S. Saralamba, R. Aguas et al., Hyperparasitaemia and low dosing are an important source of anti-malarial drug resistance, Malar J, vol.8, p.253, 2009.

V. Melendez, Metabolic profile of artesunate and DHA using human plasma, liver, and hepatocytes, Annual progress report. Pennsylvania, p.214, 2003.

T. M. Davis, H. L. Phuong, K. F. Ilett, N. C. Hung, K. T. Batty et al., Pharmacokinetics and pharmacodynamics of intravenous artesunate in severe falciparum malaria, Antimicrob Agents Chemother, vol.45, issue.1, pp.181-187, 2001.

S. Yeung, W. Van-damme, D. Socheat, N. J. White, and A. Mills, Access to artemisinin combination therapy for malaria in remote areas of Cambodia, Malar J, vol.7, p.96, 2008.

J. L. Cohen, E. Yavuz, A. Morris, J. Arkedis, and O. Sabot, Do patients adhere to overthe-counter artemisinin combination therapy for malaria? evidence from an intervention study in Uganda, Malar J, vol.11, p.83, 2012.

H. Lemma, C. Lofgren, S. Sebastian, and M. , Adherence to a six-dose regimen of artemether-lumefantrine among uncomplicated Plasmodium falciparum patients in the Tigray Region, Ethiopia. Malar J, vol.10, p.349, 2011.

P. N. Newton, R. Mcgready, F. Fernandez, M. D. Green, M. Sunjio et al., Manslaughter by fake artesunate in Asia-will Africa be next, PLoS Med, vol.3, issue.6, p.197, 2006.

S. Sengaloundeth, M. D. Green, F. M. Fernandez, O. Manolin, K. Phommavong et al., A stratified random survey of the proportion of poor quality oral artesunate sold at medicine outlets in the Lao PDR-implications for therapeutic failure and drug resistance, Malar J, vol.8, p.172, 2009.

M. El-duah and K. Ofori-kwakye, Substandard artemisinin-based antimalarial medicines in licensed retail pharmaceutical outlets in Ghana, vol.49, pp.131-140, 2012.

C. Amaratunga, S. Sreng, S. Suon, E. S. Phelps, K. Stepniewska et al., Artemisinin-resistant Plasmodium falciparum in Pursat province, western Cambodia: a parasite clearance rate study, Lancet Infect Dis, vol.12, issue.11, pp.851-859, 2012.

H. Noedl, Y. Se, S. Sriwichai, K. Schaecher, P. Teja-isavadharm et al., Artemisinin resistance in Cambodia: a clinical trial designed to address an emerging problem in Southeast Asia. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, vol.51, pp.82-91, 2010.

R. Leang, A. Barrette, D. M. Bouth, D. Menard, R. Abdur et al., Efficacy of dihydroartemisinin-piperaquine for treatment of uncomplicated Plasmodium falciparum and Plasmodium vivax in Cambodia, Antimicrob Agents Chemother, vol.57, issue.2, pp.818-844, 2008.

D. Das, R. Tripura, A. P. Phyo, K. M. Lwin, J. Tarning et al., Effect of high-dose or split-dose artesunate on parasite clearance in artemisinin-resistant falciparum malaria. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, vol.56, pp.48-58, 2013.

M. Ghorbal, M. Gorman, C. R. Macpherson, R. M. Martins, A. Scherf et al., Genome editing in the human malaria parasite Plasmodium falciparum using the CRISPR-Cas9 system, Nat Biotechnol, vol.32, issue.8, pp.819-840, 2014.

J. Straimer, N. F. Gnadig, B. Witkowski, C. Amaratunga, V. Duru et al., Drug resistance. K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates, Science, vol.347, issue.6220, pp.428-459, 2015.

C. Sibley, Artemisinin resistance: the more we know, the more complicated it appears, J Infect Dis, vol.211, issue.5, pp.667-676, 2015.

O. Miotto, R. Amato, E. A. Ashley, B. Macinnis, J. Almagro-garcia et al., Genetic architecture of artemisinin-resistant Plasmodium falciparum, Nat Genet, vol.47, issue.3, pp.226-260, 2015.

S. M. Taylor, C. M. Parobek, D. K. Deconti, K. Kayentao, S. O. Coulibaly et al., Absence of putative artemisinin resistance mutations among Plasmodium falciparum in Sub-Saharan Africa: a molecular epidemiologic study, J Infect Dis, vol.211, issue.5, pp.680-688, 2015.

K. Murai, R. Culleton, T. Hisaoka, H. Endo, and T. Mita, Global distribution of polymorphisms associated with delayed Plasmodium falciparum parasite clearance following artemisinin treatment: genotyping of archive blood samples, Parasitol Int, vol.64, issue.3, pp.267-73, 2015.

A. Mbengue, S. Bhattacharjee, T. Pandharkar, H. Liu, G. Estiu et al., A molecular mechanism of artemisinin resistance in Plasmodium falciparum malaria, Nature, vol.520, issue.7549, pp.683-690, 2015.

L. Arnold, R. K. Tyagi, P. Mejia, N. Van-rooijen, J. L. Perignon et al., Analysis of innate defences against Plasmodium falciparum in immunodeficient mice, Malar J, vol.9, p.197, 2010.

P. Druilhe, F. Spertini, D. Soesoe, G. Corradin, P. Mejia et al., A malaria vaccine that elicits in humans antibodies able to kill Plasmodium falciparum, PLoS Med, vol.2, issue.11, p.344, 2005.

M. Chavchich, L. Gerena, J. Peters, N. Chen, Q. Cheng et al., Role of pfmdr1 amplification and expression in induction of resistance to artemisinin derivatives in Plasmodium falciparum, Antimicrob Agents Chemother, vol.54, issue.6, pp.2455-64, 2010.

M. B. Reed, K. J. Saliba, S. R. Caruana, K. Kirk, and A. F. Cowman, Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum, Nature, vol.403, issue.6772, pp.906-915, 2000.
DOI : 10.1038/35002615

P. Lim, A. P. Alker, N. Khim, N. K. Shah, S. Incardona et al., Pfmdr1 copy number and arteminisin derivatives combination therapy failure in falciparum malaria in Cambodia, Malar J, vol.8, p.11, 2009.
DOI : 10.1186/1475-2875-8-11
URL : https://malariajournal.biomedcentral.com/track/pdf/10.1186/1475-2875-8-11

M. A. Kohanski, M. A. Depristo, and J. J. Collins, Sublethal antibiotic treatment leads to multidrug resistance via radical-induced mutagenesis, Mol Cell, vol.37, issue.3, pp.311-331, 2010.
DOI : 10.1016/j.molcel.2010.01.003
URL : https://doi.org/10.1016/j.molcel.2010.01.003

A. H. Lee and D. A. Fidock, Evidence of a Mild Mutator Phenotype in Cambodian Plasmodium falciparum Malaria Parasites, PLoS One, vol.11, issue.4, p.154166, 2016.

D. K. Gupta, A. T. Patra, L. Zhu, A. P. Gupta, and Z. Bozdech, DNA damage regulation and its role in drug-related phenotypes in the malaria parasites, Sci Rep, vol.6, p.23603, 2016.

H. Ginsburg, Progress in in silico functional genomics: the malaria Metabolic Pathways database, Trends Parasitol, vol.22, issue.6, pp.238-278, 2006.